Biography

Weixuan (Vivian) Wang is an associate in Weil’s Antitrust/Competition practice group. Her practice focuses on regulatory approval for mergers and acquisitions, civil antitrust litigation, and government investigations. She has worked on matters across a wide range of industries including pharmaceuticals, telecommunication/broadcasting, infrastructure construction, oil and gas, and business service.
Ms. Wang received her J.D., from the New York University School of Law, where she served as the Articles Editor of the Journal of Law and Liberty. She earned her LL.B and B.A. from Peking University, and LL.M from Georgetown University Law Center.
Awards and Recognition, Speaking Engagements, Guides and Resources, Latest Thinking, Firm News & Announcements
Firm News & Announcements
- Weil Advises Sanofi in its Pending $1.45 Billion Acquisition of Kymab, Ltd. Deal Brief — January 27, 2021
- Weil Advises Foley Trasimene Acquisition Corp. in its Pending $7.3 Billion Merger with Alight Solutions LLC Deal Brief — January 25, 2021